Depomed Sends Letter to Horizon Pharma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. BILL
4. MRK
5. MRNA
6. ADI
7. LOW
8. DE
9. MRVL
10. COTY

Go back to Depomed Sends Letter to Horizon Pharma

Brean Capital Remains Bullish on Horizon Pharma (HZNP) Following 2Q Beat

August 10, 2015 6:51 AM EDT

Brean Capital reiterated a Buy rating and $40 price target on Horizon Pharma (NASDAQ: HZNP) following the release of its 2Q15 earnings results. revenue was $172.8 million beating consensus estimates of $156.4. Non-GAAP EPS was $0.39 beating consensus' $0.32.

Analyst Difei Yang commented, "Given the pre-announcement of... More

Horizon Pharma (HZNP) Tops Q2 EPS by 7c

August 7, 2015 7:02 AM EDT

Horizon Pharma (NASDAQ: HZNP) reported Q2 EPS of $0.39, $0.07 better than the analyst estimate of $0.32. Revenue for the quarter came in at $172.8 million versus the consensus estimate of $156.41 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

... More

Depomed (DEPO) Sends Letter to Horizon Pharma (HZNP); Will be Open to 'Compelling Proposal'

August 7, 2015 6:32 AM EDT

Depomed (NASDAQ: DEPO) has sent the following letter to Horizon Pharma plc (NASDAQ: HZNP) ("Horizon"):

August 7, 2015

Timothy P. Walbert Chairman of the Board, President and Chief Executive OfficerHorizon Pharma plcConnaught House, 1st Floor, 1 Burlington Road Dublin 4, Ireland

Dear Tim,

In our conversation late last week, you stated that Horizon was prepared to increase its proposal and to... More